title: Regression of cutaneous intravascular lymphoma with rituximab.
abstract: Intravascular lymphoma, also known as malignant angioendotheliomatosis or angiotropic lymphoma, is a rare non-Hodgkin lymphoma that is usually fatal. It often presents with cutaneous and/or nervous system involvement, but the disease can involve any organ system. Clinical symptoms result from the occlusion of small vessels by tumor cells and fibrin. We present a case of cutaneous intravascular lymphoma successfully treated with rituximab, a recombinant antibody to CD20 antigen found on B lymphocytes.
authors.affiliation: Division of Dermatology, University of California at Los Angeles, USA.
authors.forename: Karen
authors.initials: K
authors.lastname: Han
authors.forename: Jennifer C
authors.initials: JC
authors.lastname: Haley
authors.forename: Keith
authors.initials: K
authors.lastname: Carlson
authors.forename: Lauren
authors.initials: L
authors.lastname: Pinter-Brown
authors.forename: Teresa
authors.initials: T
authors.lastname: Soriano
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006390:Hemangioendothelioma / Q000188:drug therapy*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab